B. 1. Ctinls, Actualisation de la définition des infections nosocomiales [Internet] Disponible sur: http://solidarites-sante.gouv.fr/IMG/pdf/rapport_complet.pdf 2. SPILF. Diagnostic et antibiothérapie des infections urinaires bactériennes communautaires de l'adulte, 2007.

L. Nicolle, The Paradigm Shift to Non-Treatment of Asymptomatic Bacteriuria. Pathogens, 2016.

M. Loeb, K. Brazil, L. Lohfeld, A. Mcgeer, A. Simor et al., Optimizing antibiotics in residents of nursing homes: protocol of a randomized trial, BMC Health Services Research, vol.14, issue.1, p.17, 2002.
DOI : 10.1093/ije/14.2.322

C. Kistler, S. Zimmerman, K. Scales, K. Ward, D. Weber et al., The Antibiotic Prescribing Pathway for Presumed Urinary Tract Infections in Nursing Home Residents, Journal of the American Geriatrics Society, vol.77, issue.58, 2017.
DOI : 10.1093/cid/ciw118

M. Loeb, A. Simor, L. Landry, S. Walter, M. Mcarthur et al., Antibiotic use in ontario facilities that provide chronic care, Journal of General Internal Medicine, vol.341, issue.6, p.37683, 2001.
DOI : 10.1056/NEJM199907223410403

A. Asscher, M. Sussman, W. Waters, J. Evans, H. Campbell et al., Asymptomatic Significant Bacteriuria in the Non-pregnant Woman, Br Med J. 29 mars, vol.1, issue.5647, p.8046, 1969.

Z. Trestioreanu, A. Lador, A. Sauerbrun-cutler, M. Leibovici, and L. , Antibiotics for asymptomatic bacteriuria, Cochrane Database Syst Rev. 8 avr, vol.4, p.9534, 2015.

T. Cai, S. Mazzoli, N. Mondaini, F. Meacci, G. Nesi et al., The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat?, Clin Infect Dis Off Publ Infect Dis Soc Am. sept, vol.55, issue.6, p.7717, 2012.

T. Cai, G. Nesi, S. Mazzoli, F. Meacci, P. Lanzafame et al., Asymptomatic Bacteriuria Treatment Is Associated With a Higher Prevalence of Antibiotic Resistant Strains in Women With Urinary Tract Infections, Clinical Infectious Diseases, 2015.
DOI : 10.1093/cid/civ696

K. Gupta, T. Hooton, K. Naber, B. Wullt, R. Colgan et al., International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases, Clin Infect Dis. 1 mars, vol.52, issue.5, p.10320, 2011.

R. Rubin, E. Shapiro, V. Andriole, R. Davis, and W. Stamm, Evaluation of New Anti-Infective Drugs for the Treatment of Urinary Tract Infection, Clinical Infectious Diseases, vol.15, issue.Supplement_1, p.21627, 1992.
DOI : 10.1093/clind/15.Supplement_1.S216

B. Rogers, P. Ingram, N. Runnegar, M. Pitman, J. Freeman et al., Community-Onset Escherichia coli Infection Resistant to Expanded-Spectrum Cephalosporins in Low-Prevalence Countries, Antimicrobial Agents and Chemotherapy, vol.58, issue.4, p.212634, 2014.
DOI : 10.1128/AAC.02052-13

J. Karlowsky, P. Lagacé-wiens, P. Simner, M. Decorby, H. Adam et al., Antimicrobial Resistance in Urinary Tract Pathogens in Canada from, Antimicrob Agents Chemother. juill, vol.55, issue.7, p.316975, 2007.

K. Park, W. Oh, E. Kim, S. Park, J. Hur et al., Factors associated with ciprofloxacin- and cefotaxime-resistant Escherichia coli in women with acute pyelonephritis in the emergency department, International Journal of Infectious Diseases, vol.23, p.813, 2014.
DOI : 10.1016/j.ijid.2013.12.021

T. Johansen, H. Botto, M. Cek, M. Grabe, P. Tenke et al., Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system, International Journal of Antimicrobial Agents, vol.38, p.6470, 2011.
DOI : 10.1016/j.ijantimicag.2011.09.009

M. Falagas, I. Kotsantis, E. Vouloumanou, and P. Rafailidis, Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: A meta-analysis of randomized controlled trials, Journal of Infection, vol.58, issue.2, p.91102, 2009.
DOI : 10.1016/j.jinf.2008.12.009

T. Christiaens, D. Meyere, M. Verschraegen, G. Peersman, W. Heytens et al., Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women, Br J Gen Pract. sept, vol.52, issue.482, p.72934, 2002.

S. Ferry, S. Holm, H. Stenlund, R. Lundholm, and T. Monsen, The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study, Scandinavian Journal of Infectious Diseases, vol.17, issue.231, p.296301, 2004.
DOI : 10.2165/00003495-199100424-00005

J. Bleidorn, I. Gágyor, M. Kochen, K. Wegscheider, and E. Hummers-pradier, Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection? - Results of a randomized controlled pilot trial, BMC Medicine, vol.13, issue.Suppl A, p.30, 2010.
DOI : 10.3310/hta13190

P. Little, M. Moore, S. Turner, K. Rumsby, G. Warner et al., Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial, BMJ, vol.340, issue.feb05 1, 2010.
DOI : 10.1136/bmj.c199

B. Knottnerus, S. Geerlings, E. Van-charante, and G. Ter-riet, Women with symptoms of uncomplicated urinary tract infection are often willing to delay antibiotic treatment: a prospective cohort study, BMC Family Practice, vol.12, issue.1, p.71, 2013.
DOI : 10.1186/1471-2334-12-146

I. Gágyor, J. Bleidorn, M. Kochen, G. Schmiemann, K. Wegscheider et al., Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial. The BMJ. 23 déc 2015

B. Foxman, Epidemiology of urinary tract infections: incidence, morbidity, and economic costs, The American Journal of Medicine, vol.113, issue.1, pp.5-13, 2002.
DOI : 10.1016/S0002-9343(02)01054-9

L. Rossignol, S. Vaux, S. Maugat, A. Blake, R. Barlier et al., Incidence of urinary tract infections and antibiotic resistance in the outpatient setting: a cross-sectional study, Infection, vol.5, issue.1, p.3340, 2017.
DOI : 10.1586/14737167.5.4.457

URL : https://hal.archives-ouvertes.fr/hal-01324986

J. Anger, C. Saigal, M. Wang, and E. Yano, Urologic Disease Burden in the United States: Veteran Users of Department of Veterans Affairs Healthcare, Urology, vol.72, issue.1, p.3741, 2008.
DOI : 10.1016/j.urology.2007.11.163

A. Ellis and S. Verma, Quality of Life in Women With Urinary Tract Infections: Is Benign Disease a Misnomer?, The Journal of the American Board of Family Medicine, vol.13, issue.6, p.3927, 2000.
DOI : 10.3122/15572625-13-6-392

B. Foxman, Urinary Tract Infection Syndromes, Infectious Disease Clinics of North America, vol.28, issue.1, p.113, 2014.
DOI : 10.1016/j.idc.2013.09.003

K. Keating, E. Perfetto, and P. Subedi, Economic burden of uncomplicated urinary tract infections: direct, indirect and intangible costs, Expert Review of Pharmacoeconomics & Outcomes Research, vol.15, issue.4, p.45766, 2005.
DOI : 10.1016/0732-8893(92)90136-H

S. Dason, J. Dason, and A. Kapoor, Guidelines for the diagnosis and management of recurrent urinary tract infection in women, Can Urol Assoc J. 1 oct, p.31622, 2011.

C. Mabeck, Treatment of uncomplicated urinary tract infection in non-pregnant women, Postgraduate Medical Journal, vol.48, issue.556, p.6975, 1972.
DOI : 10.1136/pgmj.48.556.69

T. Hooton, Uncomplicated Urinary Tract Infection, New England Journal of Medicine, vol.366, issue.11, p.102837, 2012.
DOI : 10.1056/NEJMcp1104429

D. Scholes, T. Hooton, P. Roberts, A. Stapleton, K. Gupta et al., Risk Factors for Recurrent Urinary Tract Infection in Young Women, The Journal of Infectious Diseases, vol.182, issue.4, p.117782, 2000.
DOI : 10.1086/315827

J. Stern, Y. Hsieh, and A. Schaeffer, Residual Urine in an Elderly Female Population: Novel Implications for Oral Estrogen Replacement and Impact on Recurrent Urinary Tract Infection, The Journal of Urology, vol.171, issue.2, 2004.
DOI : 10.1097/01.ju.0000107261.64927.b3

R. Raz, Y. Gennesin, J. Wasser, Z. Stoler, S. Rosenfeld et al., Recurrent Urinary Tract Infections in Postmenopausal Women, Clinical Infectious Diseases, vol.30, issue.1, p.1526, 2000.
DOI : 10.1086/313596

T. Hawn, D. Scholes, S. Li, H. Wang, Y. Yang et al., Toll-Like Receptor Polymorphisms and Susceptibility to Urinary Tract Infections in Adult Women, PLoS ONE, vol.4, issue.6, p.5990, 2009.
DOI : 10.1371/journal.pone.0005990.s002

K. Gupta, A. Stapleton, T. Hooton, P. Roberts, C. Fennell et al., Inverse Association of H2O2-Producing Lactobacilli and Vaginal Escherichia coli Colonization in Women with Recurrent Urinary Tract Infections, Journal of Infectious Diseases, vol.178, issue.2, p.44650, 1998.
DOI : 10.1086/515635

G. Anderson, J. Palermo, J. Schilling, R. Roth, J. Heuser et al., Intracellular Bacterial Biofilm-Like Pods in Urinary Tract Infections, Science, vol.301, issue.5629, p.1057, 2003.
DOI : 10.1126/science.1084550

D. Schwartz, S. Chen, S. Hultgren, and P. Seed, Population Dynamics and Niche Distribution of Uropathogenic Escherichia coli during Acute and Chronic Urinary Tract Infection, Infection and Immunity, vol.79, issue.10, p.42509, 2011.
DOI : 10.1128/IAI.05339-11

S. Chen, M. Wu, J. Henderson, T. Hooton, M. Hibbing et al., Genomic Diversity and Fitness of E. coli Strains Recovered from the Intestinal and Urinary Tracts of Women with Recurrent Urinary Tract Infection, Science Translational Medicine, vol.103, issue.15, pp.184-60, 2013.
DOI : 10.1073/pnas.0600938103

D. Rosen, T. Hooton, W. Stamm, P. Humphrey, and S. Hultgren, Detection of Intracellular Bacterial Communities in Human Urinary Tract Infection, PLoS Medicine, vol.265, issue.12, p.329, 2007.
DOI : 10.1371/journal.pmed.0040329.t002

L. Robino, P. Scavone, L. Araujo, G. Algorta, P. Zunino et al., Intracellular Bacteria in the Pathogenesis of Escherichia coli Urinary Tract Infection in Children, Clinical Infectious Diseases, vol.59, issue.11, p.15864, 2014.
DOI : 10.1093/cid/ciu634

K. Ejrnaes, D. Sandvang, B. Lundgren, S. Ferry, S. Holm et al., Pulsed-Field Gel Electrophoresis Typing of Escherichia coli Strains from Samples Collected before and after Pivmecillinam or Placebo Treatment of Uncomplicated Community-Acquired Urinary Tract Infection in Women, Journal of Clinical Microbiology, vol.44, issue.5, p.177681, 2006.
DOI : 10.1128/JCM.44.5.1776-1781.2006

C. Czaja, W. Stamm, A. Stapleton, P. Roberts, T. Hawn et al., Prospective Cohort Study of Microbial and Inflammatory Events Immediately Preceding Escherichia coli Recurrent Urinary Tract Infection in Women, J Infect Dis. 1 août, vol.200, issue.4, p.52836, 2009.

R. Ikähelmo, A. Siitonen, T. Heiskanen, U. Kärkkäinen, P. Kuosmanen et al., Recurrence of Urinary Tract Infection in a Primary Care Setting: Analysis of a I-Year Follow-up of 179 Women, Clinical Infectious Diseases, vol.22, issue.1, p.919, 1996.
DOI : 10.1093/clinids/22.1.91

M. Kerrn, C. Struve, J. Blom, N. Frimodt-møller, and K. Krogfelt, Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice, Journal of Antimicrobial Chemotherapy, vol.55, issue.3, p.3836, 2005.
DOI : 10.1093/jac/dki002

M. Blango and M. Mulvey, Persistence of Uropathogenic Escherichia coli in the Face of Multiple Antibiotics, Antimicrobial Agents and Chemotherapy, vol.54, issue.5, p.185563, 2010.
DOI : 10.1128/AAC.00014-10

A. Huttner, C. Hatz, G. Van-den-dobbelsteen, D. Abbanat, A. Hornacek et al., Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial, The Lancet Infectious Diseases, vol.17, issue.5, p.52837, 2017.
DOI : 10.1016/S1473-3099(17)30108-1

B. Köves, E. Salvador, J. Grönberg-hernández, J. Zdziarski, B. Wullt et al., Rare Emergence of Symptoms during Long-Term Asymptomatic Escherichia coli 83972 Carriage without an Altered Virulence Factor Repertoire, The Journal of Urology, vol.191, issue.2, p.51928, 2014.
DOI : 10.1016/j.juro.2013.07.060

C. Czaja, D. Scholes, T. Hooton, and W. Stamm, Population-Based Epidemiologic Analysis of Acute Pyelonephritis, Clinical Infectious Diseases, vol.45, issue.3, p.27380, 2007.
DOI : 10.1086/519268

M. Ki, T. Park, B. Choi, and B. Foxman, The Epidemiology of Acute Pyelonephritis in South Korea, 1997-1999, American Journal of Epidemiology, vol.160, issue.10, p.98593, 2004.
DOI : 10.1093/aje/kwh308

U. Chang, H. Kim, Y. Noh, and S. Wie, A comparison of the clinical characteristics of elderly and non-elderly women with community-onset, non-obstructive acute pyelonephritis, The Korean Journal of Internal Medicine, vol.30, issue.3, p.37283, 2015.
DOI : 10.3904/kjim.2015.30.3.372

M. Ortega, F. Marco, A. Soriano, M. Almela, J. Martínez et al., Epidemiology and prognostic determinants of bacteremic acute pyelonephritis in women, Journal of Infection, vol.66, issue.2, p.1936, 2013.
DOI : 10.1016/j.jinf.2012.10.015

S. Lee, Y. Kim, and D. Chung, Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis, Journal of Infection, vol.62, issue.2, p.15964, 2011.
DOI : 10.1016/j.jinf.2010.10.009

J. Lee, Y. Lee, and J. Cho, Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER, Journal of Infection and Chemotherapy, vol.18, issue.1, p.1303, 2012.
DOI : 10.1007/s10156-011-0289-z

C. Van-nieuwkoop, J. Van-'t-wout, I. Spelt, M. Becker, E. Kuijper et al., Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment, Journal of Infection, vol.60, issue.2, p.11421, 2010.
DOI : 10.1016/j.jinf.2009.11.008

S. Efstathiou, A. Pefanis, D. Tsioulos, I. Zacharos, A. Tsiakou et al., Acute Pyelonephritis in Adults, Archives of Internal Medicine, vol.163, issue.10, p.120612, 2003.
DOI : 10.1001/archinte.163.10.1206

D. «. Paterson, ???Collateral Damage??? from Cephalosporin or Quinolone Antibiotic Therapy, Clinical Infectious Diseases, vol.38, issue.Supplement_4, p.3415, 2004.
DOI : 10.1086/382690

URL : https://academic.oup.com/cid/article-pdf/38/Supplement_4/S341/789031/38-Supplement_4-S341.pdf

C. Costelloe, C. Metcalfe, A. Lovering, D. Mant, and A. Hay, Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis, BMJ, vol.340, issue.may18 2, pp.2096-2096, 0182.
DOI : 10.1136/bmj.c2096

A. Vellinga, S. Tansey, B. Hanahoe, K. Bennett, A. Murphy et al., Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model, Journal of Antimicrobial Chemotherapy, vol.67, issue.10, p.252330, 2012.
DOI : 10.1093/jac/dks222

J. Parienti, J. Lucet, A. Lefort, L. Armand-lefèvre, M. Wolff et al., Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance, American Journal of Infection Control, vol.43, issue.9, 2015.
DOI : 10.1016/j.ajic.2015.05.033

F. Caron, Évolution des recommandations pour la prise en charge des infections urinaires communautaires de l'adulte. 18es Journées Nationales d'Infectiologie (JNI); 2017 juin

K. Laupland, T. Ross, J. Pitout, D. Church, and D. Gregson, Community-onset Urinary Tract Infections: A Population-based Assessment, Infection, vol.35, issue.3, p.150, 2007.
DOI : 10.1007/s15010-007-6180-2

T. Griebling, UROLOGIC DISEASES IN AMERICA PROJECT: TRENDS IN RESOURCE USE FOR URINARY TRACT INFECTIONS IN MEN, The Journal of Urology, vol.173, issue.4, p.128894, 2005.
DOI : 10.1097/01.ju.0000155595.98120.8e

B. Foxman, K. Klemstine, and P. Brown, Acute Pyelonephritis in US Hospitals in 1997, Annals of Epidemiology, vol.13, issue.2, p.14450, 2003.
DOI : 10.1016/S1047-2797(02)00272-7

M. Etienne, P. Chavanet, L. Sibert, F. Michel, H. Levesque et al., Acute bacterial prostatitis: heterogeneity in diagnostic criteria and management. Retrospective multicentric analysis of 371 patients diagnosed with acute prostatitis, BMC Infectious Diseases, vol.11, issue.Suppl 3, 2008.
DOI : 10.1016/S0733-8627(05)70210-8

K. Charalabopoulos, G. Karachalios, D. Baltogiannis, A. Charalabopoulos, X. Giannakopoulos et al., Penetration of Antimicrobial Agents into the Prostate, Chemotherapy, vol.49, issue.6, p.26979, 2003.
DOI : 10.1159/000074526

K. Nanmoku, N. Ishikawa, A. Kurosawa, T. Shimizu, T. Kimura et al., Clinical characteristics and outcomes of adenovirus infection of the urinary tract after renal transplantation, Transplant Infectious Disease, vol.18, issue.5, p.2349, 2016.
DOI : 10.1016/j.bbmt.2011.09.007

T. Walls, A. Shankar, and D. Shingadia, Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients, The Lancet Infectious Diseases, vol.3, issue.2, p.7986, 2003.
DOI : 10.1016/S1473-3099(03)00515-2

M. Siguier, P. Sellier, and J. Bergmann, BK-virus infections: A literature review, M??decine et Maladies Infectieuses, vol.42, issue.5, p.1817, 2012.
DOI : 10.1016/j.medmal.2012.04.011

S. Heytens, J. Boelens, G. Claeys, A. Desutter, and T. Christiaens, Uropathogen distribution and antimicrobial susceptibility in uncomplicated cystitis in Belgium, a high antibiotics prescribing country: 20-year surveillance, European Journal of Clinical Microbiology & Infectious Diseases, vol.10, issue.4, p.10513, 2017.
DOI : 10.1016/S0924-8579(98)00021-1

G. Schito, K. Naber, H. Botto, J. Palou, T. Mazzei et al., The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections, International Journal of Antimicrobial Agents, vol.34, issue.5, p.40713, 2009.
DOI : 10.1016/j.ijantimicag.2009.04.012

URL : https://hal.archives-ouvertes.fr/hal-00556347

M. Kim, U. Ha, and Y. Cho, Prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in female outpatients in South Korea: a multicentre study in 2006, International Journal of Antimicrobial Agents, vol.31, p.158, 2008.
DOI : 10.1016/j.ijantimicag.2007.07.043

S. Moffett, B. Frazee, J. Stein, B. Navab, J. Maselli et al., Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs, The American Journal of Emergency Medicine, vol.30, issue.6, p.9429, 2012.
DOI : 10.1016/j.ajem.2011.05.008

S. Farajnia, M. Alikhani, R. Ghotaslou, B. Naghili, and A. Nakhlband, Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran, International Journal of Infectious Diseases, vol.13, issue.2, p.1404, 2009.
DOI : 10.1016/j.ijid.2008.04.014

N. Pruetpongpun, T. Khawcharoenporn, P. Damronglerd, N. Suwantarat, A. Apisarnthanarak et al., Inappropriate Empirical Treatment of Uncomplicated Cystitis in Thai Women: Lessons Learned, Clinical Infectious Diseases, vol.64, issue.suppl_2, p.1158, 2017.
DOI : 10.1093/cid/cix088

D. Talan, A. Krishnadasan, F. Abrahamian, W. Stamm, and G. Moran, Prevalence and Risk Factor Analysis of Trimethoprim-Sulfamethoxazole? and Fluoroquinolone- Resistant Escherichia coli Infection among Emergency Department Patients with Pyelonephritis, Clin Infect Dis. 1 nov, vol.47, issue.9, p.11508, 2008.

D. Talan, S. Takhar, A. Krishnadasan, F. Abrahamian, W. Mower et al., Fluoroquinolone-Resistant and Extended-Spectrum ?-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, Emerg Infect Dis. sept, vol.22, issue.19, 2016.

S. Hillier, J. Bell, M. Heginbothom, Z. Roberts, F. Dunstan et al., When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data, Journal of Antimicrobial Chemotherapy, vol.58, issue.6, p.13036, 2006.
DOI : 10.1093/jac/dkl432

A. Kronenberg, S. Koenig, S. Droz, and K. Mühlemann, Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting, Clinical Microbiology and Infection, vol.17, issue.12, p.184551, 2011.
DOI : 10.1111/j.1469-0691.2011.03519.x

D. Mouy, D. Lepargneur, J. Auriol, J. Bandler, H. Larribet et al., Evolution des fréquences d'isolement et de la résistance des souches d'Escherichia coli isolées d'infections urinaires en pratique de ville de, Médecine Mal Infect. 1 juin, vol.24, p.53942, 1986.

D. Mouy, D. Cavallo, J. Fabre, R. Garrabe, E. Grobost et al., Les entérobactéries isolées d'infections urinaires en pratique de ville : étude AFORCOPIBIO 1995, Médecine Mal Infect. 1 juin, vol.27, p.6425, 1997.

F. Goldstein, Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Multicentre Study Group, Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol. févr, vol.19, issue.2, p.1127, 2000.

G. Kahlmeter and H. Poulsen, Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO??SENS study revisited, International Journal of Antimicrobial Agents, vol.39, issue.1
DOI : 10.1016/j.ijantimicag.2011.09.013

K. Gordon and R. Jones, Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program, Diagn Microbiol Infect Dis. 1 avr, vol.45, issue.4, p.295301, 2000.

I. Linhares, T. Raposo, A. Rodrigues, and A. Almeida, Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000???2009), BMC Infectious Diseases, vol.58, issue.1, p.19, 2000.
DOI : 10.1093/jac/dkl243

M. Etienne, H. Van-elslande, J. Choplin-renard, M. Pestel-caron, and F. Caron, Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: Rates and predicting factors, M??decine et Maladies Infectieuses, vol.44, issue.5, p.21722, 2014.
DOI : 10.1016/j.medmal.2014.03.003

D. Martin, S. Fougnot, F. Grobost, S. Thibaut-jovelin, F. Ballereau et al., Prevalence of extended-spectrum beta-lactamase producing Escherichia coli in??community-onset urinary tract infections in France in 2013, Journal of Infection, vol.72, issue.2, p.2016, 2016.
DOI : 10.1016/j.jinf.2015.11.009

URL : https://hal.archives-ouvertes.fr/hal-01246265

G. Wright, The antibiotic resistome: the nexus of chemical and genetic diversity, Nature Reviews Microbiology, vol.78, issue.3, p.17586, 2007.
DOI : 10.7164/antibiotics.56.135

J. Davies and D. Davies, Origins and Evolution of Antibiotic Resistance, Microbiology and Molecular Biology Reviews, vol.74, issue.3, p.41733, 2010.
DOI : 10.1128/MMBR.00016-10

C. Smillie, M. Smith, J. Friedman, O. Cordero, L. David et al., Ecology drives a global network of gene exchange connecting the human microbiome, Nature, vol.37, issue.7376, p.2414, 2011.
DOI : 10.1093/nar/gkn656

J. Beaber, B. Hochhut, and M. Waldor, SOS response promotes horizontal dissemination of antibiotic resistance genes, Nature, vol.427, issue.6969, p.724, 2004.
DOI : 10.1038/nature02241

L. Feld, S. Schjørring, K. Hammer, T. Licht, M. Danielsen et al., Selective pressure affects transfer and establishment of a Lactobacillus plantarum resistance plasmid in the gastrointestinal environment, Journal of Antimicrobial Chemotherapy, vol.61, issue.4, p.84552, 2008.
DOI : 10.1093/jac/dkn033

F. Aarestrup, H. Wegener, and P. Collignon, Resistance in bacteria of the food chain: epidemiology and control strategies, Expert Review of Anti-infective Therapy, vol.11, issue.5, p.73350, 2008.
DOI : 10.3201/eid1112.010977

O. Neill and J. , Tackling drug-resistant infection globally: Final report and recommendations [Internet]

K. Laupland, D. Church, J. Vidakovich, M. Mucenski, and J. Pitout, Community-onset extended-spectrum ??-lactamase (ESBL) producing Escherichia coli: Importance of international travel, Journal of Infection, vol.57, issue.6, p.4418, 2008.
DOI : 10.1016/j.jinf.2008.09.034

A. Kantele, T. Lääveri, S. Mero, K. Vilkman, S. Pakkanen et al., Antimicrobials Increase Travelers' Risk of Colonization by Extended-Spectrum Betalactamase-Producing Enterobacteriaceae, Clinical Infectious Diseases, vol.60, issue.6, p.83746, 2015.
DOI : 10.1093/cid/ciu957

R. Sender, S. Fuchs, and M. R. , Revised Estimates for the Number of Human and Bacteria Cells in the Body, PLOS Biology, vol.347, issue.8, p.1002533, 2016.
DOI : 10.1371/journal.pbio.1002533.s002

I. Adlerberth, D. Strachan, P. Matricardi, S. Ahrné, L. Orfei et al., Gut microbiota and development of atopic eczema in 3 European birth cohorts, Journal of Allergy and Clinical Immunology, vol.120, issue.2, p.34350, 2007.
DOI : 10.1016/j.jaci.2007.05.018

K. Laupland and D. Church, Population-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections, Clinical Microbiology Reviews, vol.27, issue.4, p.64764, 2014.
DOI : 10.1016/S1473-3099(10)70143-2

C. Kliebe, B. Nies, J. Meyer, R. Tolxdorff-neutzling, and B. Wiedemann, Evolution of plasmid-coded resistance to broad-spectrum cephalosporins., Antimicrobial Agents and Chemotherapy, vol.28, issue.2, p.3027, 1985.
DOI : 10.1128/AAC.28.2.302

R. Bonnet, Growing Group of Extended-Spectrum ??-Lactamases: the CTX-M Enzymes, Antimicrobial Agents and Chemotherapy, vol.48, issue.1, p.114, 2004.
DOI : 10.1128/AAC.48.1.1-14.2004

R. Cantón, J. González-alba, and J. Galán, CTX-M Enzymes: Origin and Diffusion. Front Microbiol. 2 avr 2012

M. Nicolas-chanoine, X. Bertrand, and J. Madec, Escherichia coli ST131, an Intriguing Clonal Group, Clinical Microbiology Reviews, vol.27, issue.3, p.54374, 2014.
DOI : 10.1128/CMR.00125-13

URL : https://hal.archives-ouvertes.fr/hal-01061609

T. Kudinha, J. Johnson, S. Andrew, F. Kong, P. Anderson et al., Distribution of phylogenetic groups, sequence type ST131, and virulence-associated traits among Escherichia coli isolates from men with pyelonephritis or cystitis and healthy controls, Clinical Microbiology and Infection, vol.19, issue.4, p.17380, 2013.
DOI : 10.1111/1469-0691.12123

S. Brisse, L. Diancourt, C. Laouénan, M. Vigan, V. Caro et al., Phylogenetic Distribution of CTX-M- and Non-Extended-Spectrum-??-Lactamase-Producing Escherichia coli Isolates: Group B2 Isolates, Except Clone ST131, Rarely Produce CTX-M Enzymes, Journal of Clinical Microbiology, vol.50, issue.9, p.297481, 2012.
DOI : 10.1128/JCM.00919-12

L. López-cerero, M. Navarro, M. Bellido, A. Martín-peña, L. Viñas et al., Escherichia coli belonging to the worldwide emerging epidemic clonal group O25b/ST131: risk factors and clinical implications, Journal of Antimicrobial Chemotherapy, vol.69, issue.3, p.80914, 2014.
DOI : 10.1093/jac/dkt405

L. Logan and R. Weinstein, The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace, The Journal of Infectious Diseases, vol.215, issue.suppl_1, p.2836, 2017.
DOI : 10.1093/infdis/jiw282

K. Vardakas, G. Tansarli, P. Rafailidis, and M. Falagas, Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum ??-lactamases: a systematic review and meta-analysis, Journal of Antimicrobial Chemotherapy, vol.67, issue.12, p.2793803, 2012.
DOI : 10.1093/jac/dks301

D. Livermore and P. Tulkens, Temocillin revived, Journal of Antimicrobial Chemotherapy, vol.63, issue.2, p.2435, 2008.
DOI : 10.1093/jac/dkn511

URL : https://academic.oup.com/jac/article-pdf/63/2/243/2105205/dkn511.pdf

J. Ghuysen, Molecular structures of penicillin-binding proteins and beta-lactamases, Trends Microbiol. oct, vol.2, issue.10, p.37280, 1994.

P. Giesbrecht, T. Kersten, H. Maidhof, and J. Wecke, Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin, Microbiol Mol Biol Rev MMBR. déc, vol.62, issue.4, p.1371414, 1998.

K. Bush and G. Jacoby, Updated functional classification of beta-lactamases, Antimicrob Agents Chemother. mars, vol.54, issue.3, p.96976, 2010.

R. Ambler, The structure of beta-lactamases, Philos Trans R Soc Lond B Biol Sci. 16 mai, vol.289, p.32131, 1036.

K. Bush, G. Jacoby, and A. Medeiros, A functional classification scheme for betalactamases and its correlation with molecular structure, Antimicrob Agents Chemother. juin, vol.39, issue.6, p.121133, 1995.

B. Slocombe, M. Basker, P. Bentley, J. Clayton, M. Cole et al., BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans., Antimicrobial Agents and Chemotherapy, vol.20, issue.1, p.3846, 1981.
DOI : 10.1128/AAC.20.1.38

R. Labia, P. Baron, J. Masson, G. Hill, and M. Cole, Affinity of temocillin for Escherichia coli K-12 penicillin-binding proteins., Antimicrobial Agents and Chemotherapy, vol.26, issue.3, pp.335-338, 1984.
DOI : 10.1128/AAC.26.3.335

K. Bush, S. Smith, S. Ohringer, S. Tanaka, and D. Bonner, Improved sensitivity in assays for binding of novel beta-lactam antibiotics to penicillin-binding proteins of Escherichia coli., Antimicrobial Agents and Chemotherapy, vol.31, issue.8, p.12713, 1987.
DOI : 10.1128/AAC.31.8.1271

K. Jules and H. Neu, Antibacterial activity and beta-lactamase stability of temocillin., Antimicrobial Agents and Chemotherapy, vol.22, issue.3, p.45360, 1982.
DOI : 10.1128/AAC.22.3.453

R. Malottke and J. Potel, Antibacterial activity of temocillin, Drugs, vol.29, p.6773, 1985.

A. Bauernfeind, Bacteriostatic and Bactericidal Activity of Penicillins at Constant and Variable Concentrations, Drugs, vol.29, issue.Supplement 5, p.914, 1985.
DOI : 10.2165/00003495-198500295-00004

S. Bonacorsi, F. Fitoussi, S. Lhopital, and E. Bingen, Comparative In Vitro Activities of Meropenem, Imipenem, Temocillin, Piperacillin, and Ceftazidime in Combination with Tobramycin, Rifampin, or Ciprofloxacin against Burkholderia cepacia Isolates from Patients with Cystic Fibrosis, Antimicrob Agents Chemother. 2 janv, vol.43, issue.2, p.2137, 1999.

H. Acker, E. Snick, H. Nelis, and T. Coenye, In vitro activity of temocillin against planktonic and sessile Burkholderia cepacia complex bacteria, J Cyst Fibros. 1 déc, vol.9, issue.6, p.4504, 2010.

H. Van-landuyt, J. Boelaert, P. Piot, and L. Verbist, In Vitro Activity of Temocillin against Clinical Isolates, Drugs, vol.29, issue.Supplement 5, p.18, 1985.
DOI : 10.2165/00003495-198500295-00003

A. Jephcott and S. Egglestone, In Vitro Activity of Temocillin Against Neisseria Gonorrhoeae Including Penicillinase-Producing Strains, Drugs, vol.29, issue.Supplement 5, p.1823, 1985.
DOI : 10.2165/00003495-198500295-00006

P. Fuchs, A. Barry, R. Jones, and C. Thornsberry, Temocillin: In vitro activity against 734 selected clinical isolates, including ??-lactamase-producing strains, Diagnostic Microbiology and Infectious Disease, vol.2, issue.1, p.5563, 1984.
DOI : 10.1016/0732-8893(84)90023-3

L. Verbist, In vitro activity of temocillin (BRL 17421), a novel beta-lactamase-stable penicillin., Antimicrobial Agents and Chemotherapy, vol.22, issue.1, p.15761, 1982.
DOI : 10.1128/AAC.22.1.157

J. Buyck, S. Guénard, P. Plésiat, P. Tulkens, and F. Bambeke, Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis, Journal of Antimicrobial Chemotherapy, vol.67, issue.3, p.7715, 2012.
DOI : 10.1093/jac/dkr543

H. Chalhoub, D. Pletzer, H. Weingart, Y. Braun, M. Tunney et al., Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic, Scientific Reports, vol.8, p.40208, 2017.
DOI : 10.1371/journal.pone.0080514

A. Matagne, M. Ghuysen, and J. Frère, -lactamases and mechanism-based inactivators: a kinetic study and an overview, Biochemical Journal, vol.295, issue.3, pp.705-711, 1993.
DOI : 10.1042/bj2950705

N. Woodford, P. Tierno, K. Young, L. Tysall, M. Palepou et al., Outbreak of Klebsiella pneumoniae Producing a New Carbapenem- Hydrolyzing Class A ??-Lactamase, KPC-3, in a New York Medical Center, Antimicrobial Agents and Chemotherapy, vol.48, issue.12, p.47939, 2004.
DOI : 10.1128/AAC.48.12.4793-4799.2004

D. Fournier, C. Chirouze, J. Leroy, P. Cholley, D. Talon et al., Alternatives to carbapenems in ESBL-producing Escherichia coli infections, M??decine et Maladies Infectieuses, vol.43, issue.2, p.626, 2013.
DOI : 10.1016/j.medmal.2013.01.006

URL : https://hal.archives-ouvertes.fr/hal-00802661

A. Mischnik, P. Baumert, A. Hamprecht, A. Rohde, S. Peter et al., Susceptibility to penicillin derivatives among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission, Diagnostic Microbiology and Infectious Disease, vol.87, issue.1
DOI : 10.1016/j.diagmicrobio.2016.09.012

H. Rodriguez-villalobos, V. Malaviolle, J. Frankard, R. Mendonça, . De et al., In vitro activity of temocillin against extended spectrum ??-lactamase-producing Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.57, issue.4, p.7714, 2006.
DOI : 10.1093/jac/dkl046

D. Livermore, R. Hope, E. Fagan, M. Warner, N. Woodford et al., Activity of temocillin against prevalent ESBL- and AmpC-producing Enterobacteriaceae from south-east England, Journal of Antimicrobial Chemotherapy, vol.57, issue.5, p.10124, 2006.
DOI : 10.1093/jac/dkl043

Y. Glupczynski, T. Huang, C. Berhin, G. Claeys, M. Delmée et al., In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units, European Journal of Clinical Microbiology & Infectious Diseases, vol.56, issue.Suppl. 5, p.77783, 2007.
DOI : 10.1179/acb.2001.044

J. Adams-haduch, B. Potoski, H. Sidjabat, D. Paterson, and Y. Doi, Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.53, issue.6, p.27001, 2009.
DOI : 10.1128/AAC.00290-09

N. Mutters, S. Zimmermann, M. Kaase, and A. Mischnik, Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production, European Journal of Clinical Microbiology & Infectious Diseases, vol.51, issue.12, p.242937, 2015.
DOI : 10.1128/JCM.01634-13

I. Zykov, A. Sundsfjord, L. Småbrekke, and Ø. Samuelsen, The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway, Infect Dis Lond Engl. févr, vol.48, issue.2, p.99107, 2010.

J. Soubirou, B. Rossi, C. Couffignal, E. Ruppé, F. Chau et al., Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15, J Antimicrob Chemother. mai, vol.70, issue.5, p.146672, 2015.

B. Hampel, M. Feike, P. Koeppe, and H. Lode, Pharmacokinetics of Temocillin in Volunteers, Drugs, vol.29, issue.Supplement 5, p.99102, 1985.
DOI : 10.2165/00003495-198500295-00020

D. Höffler and P. Koeppe, Temocillin pharmacokinetics in normal and impaired renal function, Drugs, vol.29, p.1359, 1985.

R. Brown, R. Wise, and J. Andrews, activity and the pharmacokinetics and tissue penetration in healthy volunteers, Journal of Antimicrobial Chemotherapy, vol.10, issue.4, pp.295-302, 1982.
DOI : 10.1093/jac/10.4.295

D. Overbosch, C. Van-gulpen, and M. H. , Renal clearance of temocillin in volunteers, Drugs, vol.29, p.12834, 1985.

T. Perl, M. Pfaller, A. Houston, and R. Wenzel, Effect of serum on the in vitro activities of 11 broad-spectrum antibiotics., Antimicrobial Agents and Chemotherapy, vol.34, issue.11, p.22349, 1990.
DOI : 10.1128/AAC.34.11.2234

M. Lockley, R. Brown, and R. Wise, Pharmacokinetics and Tissue Penetration of Temocillin, Drugs, vol.29, issue.Supplement 5, 1985.
DOI : 10.2165/00003495-198500295-00022

L. Baert, H. Aswarie, L. Verbist, and R. Horton, Penetration Of Temocillin Into Prostatic Tissue After Intravenous Dosing, Acta Clinica Belgica, vol.44, issue.5, p.3589, 1989.
DOI : 10.1080/17843286.1989.11718041

W. Craig, Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins, Diagnostic Microbiology and Infectious Disease, vol.22, issue.1-2, p.8996, 1995.
DOI : 10.1016/0732-8893(95)00053-D

J. Roberts, S. Paul, M. Akova, M. Bassetti, J. Waele et al., DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current ??-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?, Clinical Infectious Diseases, vol.58, issue.8, p.107283, 2014.
DOI : 10.1093/cid/ciu027

K. Alexandre, F. Chau, F. Guérin, L. Massias, A. Lefort et al., Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPCproducing Escherichia coli, J Antimicrob Chemother. juill, vol.71, issue.7, p.1899904, 2016.

D. Jongh, R. Hens, R. Basma, V. Mouton, J. Tulkens et al., Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection, Journal of Antimicrobial Chemotherapy, vol.61, issue.2, p.3828, 2008.
DOI : 10.1093/jac/dkm467

P. Laterre, X. Wittebole, S. Van-de-velde, A. Muller, J. Mouton et al., Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration, Journal of Antimicrobial Chemotherapy, vol.70, issue.3, p.8918, 2015.
DOI : 10.1093/jac/dku465

H. Mittermayer, Influence of Temocillin on Human Bowel Flora, Drugs, vol.29, issue.Supplement 5, p.438, 1985.
DOI : 10.2165/00003495-198500295-00010

R. Boon and A. Beale, Studies with temocillin in a hamster model of antibiotic-associated colitis., Antimicrobial Agents and Chemotherapy, vol.27, issue.6, p.9801, 1985.
DOI : 10.1128/AAC.27.6.980

N. Gupta, R. Smith, and I. Balakrishnan, Clinical efficacy of temocillin, Journal of Antimicrobial Chemotherapy, vol.64, issue.2, p.4313, 2009.
DOI : 10.1093/jac/dkp208

I. Balakrishnan, F. Awad-el-kariem, A. Aali, P. Kumari, R. Mulla et al., Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC ??-lactamase-producing Enterobacteriaceae, Journal of Antimicrobial Chemotherapy, vol.66, issue.11, p.262831, 2011.
DOI : 10.1093/jac/dkr317

H. Habayeb, B. Sajin, K. Patel, C. Grundy, A. Dujaili et al., Amoxicillin plus temocillin as an alternative empiric therapy for the treatment of severe hospital-acquired pneumonia: results from a retrospective audit, European Journal of Clinical Microbiology & Infectious Diseases, vol.45, issue.Suppl 5, p.16939, 2015.
DOI : 10.3947/ic.2013.45.4.351

J. Kosmidis, The Treatment of Complicated and Uncomplicated Urinary Tract Infections with Temocillin, Drugs, vol.29, issue.Supplement 5, p.1724, 1985.
DOI : 10.2165/00003495-198500295-00036

H. Asbach, E. Becker-boost, and M. Melekos, Clinical Evaluation of Temocillin in Urinary Tract Infections, Drugs, vol.29, issue.Supplement 5, p.1757, 1985.
DOI : 10.2165/00003495-198500295-00037

B. Schulze and H. Heilmann, Treatment of severe infections with temocillin. Clinical and bacteriological evaluation, Drugs, vol.29, p.2079, 1985.

H. Rodriguez-villalobos, A. Cardentey-reyes, C. Thiroux, C. Nonhoff, and M. Struelens, Comparison of four commercial methods for determining temocillin susceptibility of Escherichia coli, Journal of Antimicrobial Chemotherapy, vol.63, issue.4, p.8324, 2009.
DOI : 10.1093/jac/dkp035

T. Patel, R. Dilley, A. Williams, G. Vanstone, and I. Balakrishnan, Comparison of the Phoenix automated system, the Etest method and broth microdilution in determining temocillin susceptibility of Enterobacteriaceae, Journal of Antimicrobial Chemotherapy, vol.68, issue.7, p.16856, 2013.
DOI : 10.1093/jac/dkt049

I. Wiegand, K. Hilpert, and R. Hancock, Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances, Nature Protocols, vol.217, issue.2, p.16375, 2008.
DOI : 10.1093/jac/48.suppl_1.5

M. Seo, S. Kim, Y. Kim, J. Kim, T. Choi et al., Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea, J Korean Med Sci. août, vol.29, issue.8, p.117881, 2014.

L. Friedrich, G. Thorne, J. Steenbergen, D. Anastasiou, and L. Koeth, Evidence for daptomycin Etest lot-related MIC elevations for Staphylococcus aureus, Diagnostic Microbiology and Infectious Disease, vol.65, issue.3, p.30611, 2009.
DOI : 10.1016/j.diagmicrobio.2009.07.012

A. Bolmström, A. Karlsson, A. Engelhardt, P. Ho, P. Petersen et al., Validation and Reproducibility Assessment of Tigecycline MIC Determinations by Etest, Journal of Clinical Microbiology, vol.45, issue.8, p.24749, 2007.
DOI : 10.1128/JCM.00089-07

M. Ip, Antimicrobial susceptilities of Temocillin and other agents against Enterobacteriaceae in Hong Kong. EPoster #P1275 présenté à: ECCMID 2017

H. Pailhoriès, Temocillin: an alternative to carbapenem for multi-drug resistant Enterobacteriaceae. EPoster #EVO500 présenté à: ECCMID 2017

A. Mamod and . Mécillinam, témocilline, céfépime : sensibilité de 282 souches résistantes aux C3G. Poster P-008 présenté à: RICAI; 2016 déc

V. Courbin, Témocilline et infections urinaires à EBLSE : diamètres d'inhibition, CMI. Poster PA-01 présenté à: RICAI; 2017 déc

M. Giaime, Acitivité de la témocilline sur 92 entérobactéries productrices de BLSE, comparée à autres bêta-lactamines. Effet inoculum. RICAI; 2016 déc

D. Andes and W. Craig, Treatment of infections with ESBL-producing organisms: pharmacokinetic and pharmacodynamic considerations, Clinical Microbiology and Infection, vol.11, p.107, 2005.
DOI : 10.1111/j.1469-0691.2005.01265.x

M. Trad, L. Zhong, R. Llorin, S. Tan, M. Chan et al., Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections, Journal of Chemotherapy, vol.37, issue.1, p.259, 2017.
DOI : 10.3109/00365548.2011.553241

J. Zhou, Z. Sulaiman, R. Llorin, K. Hee, L. Lee et al., Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections, Journal of Antimicrobial Chemotherapy, vol.69, issue.9, p.251721, 2014.
DOI : 10.1093/jac/dku143

J. Andrews, G. Jevons, R. Walker, J. Ashby, and A. Fraise, Temocillin susceptibility by BSAC methodology, Journal of Antimicrobial Chemotherapy, vol.60, issue.1, p.1857, 2007.
DOI : 10.1093/jac/dkm179

B. Lamy, G. Carret, J. Flandrois, and M. Delignette-muller, How does susceptibility prevalence impact on the performance of disk diffusion susceptibility testing?, Diagnostic Microbiology and Infectious Disease, vol.49, issue.2, p.1319, 2004.
DOI : 10.1016/j.diagmicrobio.2004.01.003

URL : https://hal.archives-ouvertes.fr/hal-00427611

A. Shah, J. Justo, P. Bookstaver, J. Kohn, H. Albrecht et al., ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.61, issue.5, 2017.
DOI : 10.1128/AAC.02313-16

D. Talan, W. Stamm, T. Hooton, G. Moran, T. Burke et al., Comparison of Ciprofloxacin (7 Days) and Trimethoprim-Sulfamethoxazole (14 Days) for Acute Uncomplicated Pyelonephritis in Women, JAMA, vol.283, issue.12, p.158390, 2000.
DOI : 10.1001/jama.283.12.1583

L. Nicolle, Complicated Urinary Tract Infection in Adults, Canadian Journal of Infectious Diseases and Medical Microbiology, vol.16, issue.6, p.34960, 2005.
DOI : 10.1155/2005/385768

J. Peterson, S. Kaul, M. Khashab, A. Fisher, and J. Kahn, A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis, Urology, vol.71, issue.1, p.1722, 2008.
DOI : 10.1016/j.urology.2007.09.002

E. Shaw, N. Benito, J. Rodríguez-baño, B. Padilla, V. Pintado et al., Risk factors for severe sepsis in community-onset bacteraemic urinary tract infection: Impact of antimicrobial resistance in a large hospitalised cohort, Journal of Infection, vol.70, issue.3, p.24754, 2015.
DOI : 10.1016/j.jinf.2014.09.011

V. Buonaiuto, I. Marquez, D. Toro, I. Joya, C. Ruiz-mesa et al., Clinical and epidemiological features and prognosis of complicated pyelonephritis: a prospective observational single hospital-based study, BMC Infectious Diseases, vol.60, issue.Suppl 3, p.639, 2014.
DOI : 10.1016/j.jinf.2009.11.008

K. Tomera, E. Burdmann, O. Reyna, Q. Jiang, W. Wimmer et al., Ertapenem versus Ceftriaxone Followed by Appropriate Oral Therapy for Treatment of Complicated Urinary Tract Infections in Adults: Results of a Prospective, Randomized, Double-Blind Multicenter Study, Antimicrobial Agents and Chemotherapy, vol.46, issue.9, p.2895900, 2002.
DOI : 10.1128/AAC.46.9.2895-2900.2002

W. Wells, G. Woods, Q. Jiang, and R. Gesser, Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy, Journal of Antimicrobial Chemotherapy, vol.53, issue.suppl_2, pp.67-74, 2004.
DOI : 10.1093/jac/dkh208

C. Slimings and T. Riley, Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis, Journal of Antimicrobial Chemotherapy, vol.69, issue.4, p.88191, 2014.
DOI : 10.1093/jac/dkt477

K. Vardakas, K. Trigkidis, E. Boukouvala, and M. Falagas, Clostridium difficile infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis, International Journal of Antimicrobial Agents, vol.48, issue.1, p.110, 2016.
DOI : 10.1016/j.ijantimicag.2016.03.008

K. Vardakas, A. Konstantelias, G. Loizidis, P. Rafailidis, and M. Falagas, Risk factors for development of Clostridium difficile infection due to BI/NAP1/027 strain: a meta-analysis, International Journal of Infectious Diseases, vol.16, issue.11, pp.768-773, 2012.
DOI : 10.1016/j.ijid.2012.07.010

D. Gerding, Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficileassociated diarrhea: this is an antimicrobial resistance problem, Clin Infect Dis Off Publ Infect Dis Soc Am. 1 mars, vol.38, issue.5, p.6468, 2004.

L. Dethlefsen, M. Mcfall-ngai, and D. Relman, An ecological and evolutionary perspective on human???microbe mutualism and disease, Nature, vol.44, issue.7164, p.8118, 2007.
DOI : 10.3201/eid1109.050124

V. Schechner, E. Temkin, S. Harbarth, Y. Carmeli, and M. Schwaber, Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance, Clinical Microbiology Reviews, vol.26, issue.2, p.289307, 2013.
DOI : 10.1128/CMR.00001-13

M. Bidell, M. Opraseuth, M. Yoon, J. Mohr, and T. Lodise, Effect of prior receipt of antibiotics on the pathogen distribution and antibiotic resistance profile of key Gramnegative pathogens among patients with hospital-onset urinary tract infections, Disponible sur, 5329905.

D. Karageorgopoulos, R. Wang, X. Yu, and M. Falagas, Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens, Journal of Antimicrobial Chemotherapy, vol.67, issue.2, p.25568, 2012.
DOI : 10.1093/jac/dkr466

N. Allou, E. Cambau, L. Massias, F. Chau, and B. Fantin, Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection, Antimicrobial Agents and Chemotherapy, vol.53, issue.10, p.42927, 2009.
DOI : 10.1128/AAC.01664-08

X. Zhao and K. Drlica, Restricting the Selection of Antibiotic???Resistant Mutants: A General Strategy Derived from Fluoroquinolone Studies, Clinical Infectious Diseases, vol.33, issue.s3, pp.147-156, 2001.
DOI : 10.1086/321841

A. Marchese, M. Bozzolasco, L. Gualco, E. Debbia, G. Schito et al., Effect of fosfomycin alone and in combination with N-acetylcysteine on E. coli biofilms, International Journal of Antimicrobial Agents, vol.22, issue.2, p.95100, 2003.
DOI : 10.1016/S0924-8579(03)00232-2

A. Nilsson, O. Berg, O. Aspevall, G. Kahlmeter, and D. Andersson, Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli, Antimicrobial Agents and Chemotherapy, vol.47, issue.9, p.28508, 2003.
DOI : 10.1128/AAC.47.9.2850-2858.2003

V. De-lastours, A. Bleibtreu, F. Chau, C. Burdet, X. Duval et al., Quinoloneresistant Escherichia coli from the faecal microbiota of healthy volunteers after ciprofloxacin exposure are highly adapted to a commensal lifestyle, J Antimicrob Chemother. 1 mars, vol.69, issue.3, p.7618, 2014.

M. Knopp and D. Andersson, Amelioration of the Fitness Costs of Antibiotic Resistance Due To Reduced Outer Membrane Permeability by Upregulation of Alternative Porins, Molecular Biology and Evolution, vol.32, issue.12, p.325263, 2015.
DOI : 10.1093/molbev/msv195

P. Matzneller, Temocillin pharmokinetics in healthy volunteers after intravenous and subcutanous administration. EPoster #P1275 présenté à: ECCMID 2017

P. Grohs, S. Kernéis, B. Sabatier, M. Lavollay, E. Carbonnelle et al., Fighting the spread of AmpC-hyperproducing Enterobacteriaceae: beneficial effect of replacing ceftriaxone with cefotaxime, Journal of Antimicrobial Chemotherapy, vol.69, issue.3, p.7869, 2014.
DOI : 10.1093/jac/dkt403

J. Parienti, V. Cattoir, P. Thibon, G. Lebouvier, R. Verdon et al., Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis, Journal of Hospital Infection, vol.78, issue.2, p.11822, 2011.
DOI : 10.1016/j.jhin.2011.03.008